Skip to content
Search Classifications
Search for IPC and CPC classification codes or keywords
CPC Subgroup
C12Y 106/02004

NADPH-hemoprotein reductase (1.6.2.4), i.e. NADP-cytochrome P450-reductase

Full Title

Oxidoreductases acting on NADH or NADPH (1.6) > with a heme protein as acceptor (1.6.2) > NADPH-hemoprotein reductase (1.6.2.4), i.e. NADP-cytochrome P450-reductase

Top Applicants

Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT

  1. HARVARD UNIVERSITY US 8,321
  2. CHINESE ACADEMY OF SCIENCES 7,486
  3. UNIVERSITY OF CALIFORNIA US 7,320
  4. REGENERON PHARMACEUTICALS US 5,003
  5. INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
  6. UNIVERSITY OF PENNSYLVANIA US 4,213
  7. CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
  8. JIANGNAN UNIVERSITY 3,961
  9. ROCHE CH 3,792
  10. ILLUMINA US 3,692